MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q1 2022 Financial Report, Corporate Update
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting its financial numbers for the first quarter ending March 31, 2022. Highlights of the report include Q1 revenues of $4.9 million, up from…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q1-2022 Results, to Host Video Webcast
Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced its financial results for the quarter ended March 31, 2022. Among the highlights, the company reported a robust balance sheet with $136.6 million of working capital,…
-
Inflation Not Dampening Online Gaming as Golden Matrix Group Inc. (NASDAQ: GMGI) Accelerates Expansion
DraftKings sees no inflationary impact on player demand in first quarter report While major B2C online gaming companies struggle with exorbitant costs, Golden Matrix’s B2C model has resulted in 14 consecutive profitable quarters Golden Matrix…
-
Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Board of Directors following Tim Leslie’s Addition and Luis Merchan’s Appointment as Chairman
Luis Merchan, Flora Growth’s CEO, will serve as the new Chairman of the Board Tim Leslie, the Chairman of the company’s Advisory Board, will serve on its Board and audit committee Flora Growth’s management is…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) CEO to Present at TechCrunch’s Signature Annual Event
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that its CEO Dr. Jun Pei will speak at TechCrunch’s signature annual event TC Sessions: Mobility 2022 in San…
-
MissionIRNewsBreaks – Tingo Inc. (TMNA) Announces Q1 2022 Financial Results
Tingo (OTC: TMNA), the leading agri-fintech company operating in Africa, has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three months ended March 31, 2022. Among the…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2022 Financial, Corporate Update
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released its first quarter 2022 financial report along…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN), LGG Report on Vehicle Pack Development of Battery Cell Tech
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released an update on its partnership with Linghang Guochuang Group (“LGG”). According to the update, the two companies are working together to take solid-state…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Appointment of Cannabis Regulatory Veteran
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its appointment of regulatory veteran Holly Bell as vice president of regulatory affairs. According to the update,…
-
Knightscope, Inc.’s (NASDAQ: KSCP) Autonomous Security Robots Facilitating Situational Crime Prevention
The various opportunity-reducing methods of situational crime prevention look to increase the perceived risks of committing a crime, enhance the effort required to commit crimes, reduce rewards, and eliminate excuses for crime Knightscope’s autonomous security…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Devoting Research, Product Development to Make Drug Substances More Effective
Lexaria Bioscience Corp. (NASDAQ: LEXX) is devoting its research and product development to making drug substances more effective in the approach to treating medical conditions such as high blood pressure and, in the process, to…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update
InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced financial results for the third quarter ended March 31, 2022. “The third quarter of…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Q2 Preliminary Financial Results
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced preliminary financial results (subject to change) for its period ending March 31, 2022. Among the highlights, the company reported cash and cash equivalents…
-
Golden Matrix Group Inc. (NASDAQ: GMGI) Leading to Way to Better Player Retention, Profits
GMGI white labels turnkey online casino, sportsbook, and live gaming content solutions complete with a single wallet for players for both desktop and mobile applications Y-o-Y revenue soared 355% to $8.88 million in Q1 fiscal…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Establish Presence in the UK and EU
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced expansion of its operational footprint in Europe and the United Kingdom, furthering its international growth strategy. According…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Releases Financial Report for Q1 2022
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, is reporting its financial numbers for the first quarter 2022, the period ended March 31, 2022; the report…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Positioned for Growth Amid Compelling Market Opportunities for Expansion; Reports Financial Results
Tackling climate change opens up potentially compelling opportunities for growth for businesses driven by ESG values such as EverGen Company is eyeing growth opportunities – both nationally and internationally – as RNG gathers steam in…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Launch of Vessel in Canada, OCS Partnership
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its Vessel brand, a leader in premium cannabis accessories, secured meaningful penetration in Canada via an…
-
MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding Reach, Reports ‘Significant Balance Sheet and Operational Improvements’
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) has been strengthening its revenue streams in the states where it operates, particularly in Michigan, Florida and California of late, while also working to deal with its…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright Global Investment Conference
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its CEO Doug Drysdale will participate in a fireside chat at the H.C. Wainwright Global Investment Hybrid…
-
Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
CNS Pharmaceuticals is developing a proprietary drug candidate that has the potential to deliver a novel solution for unmet medical needs in treating an incurable brain cancer CNS’s drug candidate is called Berubicin, a powerful…
-
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Influencing the Pharmaceutical Industry
Lexaria began its human clinical study on oral nicotine alternatives, evaluating the effectiveness of its DehydraTECH-nicotine pouch performance Earlier in the year, the company also announced the commencement of its HYPER-H21-4 human clinical study on…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Experiential Event Scheduled to Coincide with National Police Week near Washington, D.C.
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, is continuing to see success through its innovative Robot Roadshow. The event, designed to grab attention, forge connections and…
-
MissionIRNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Enter Definitive Merger Agreement
Tingo (OTC: TMNA), the leading agri-fintech company operating in Africa, and MICT (NASDAQ: MICT), a financial technology business principally focused on the growth and development of a suite of consumer fintech services, today announced the…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Kernel Share Preliminary Results from Flow Feasibility Study
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), and its partner Kernel, are reporting preliminary data that confirm the ability of Kernel’s quantitative neuroimaging technology, Flow, to successfully measure…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Positive Initial Results, Progression to next Stage of Solid-State Polymer Battery Testing
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced an update on Mullen’s solid-state polymer battery testing with the Battery Innovation Center (“BIC”) in Indiana. According to the update, BIC has completed…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Webinar to Showcase Lidar Applications in Smart Infrastructure
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, together with Lidar News will host a free webinar at 10:30 a.m. PT/1:30 p.m. ET on Tuesday, May 24, 2022. The…
-
Knightscope, Inc. (NASDAQ: KSCP) Securing Physical and Intellectual Property With Autonomous Security Solutions
Intellectual property theft costs the United States $225-600 billion every year Crime, in general, has a negative economic impact of over $2 trillion annually Knightscope, through its ASRs, seeks to remedy the situation by offering…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Fourth Quarter Results; Announces Management Additions
EverGen Infrastructure reported their Q4 ‘21 quarterly results on April 21, 2022 The company reported 4Q21 revenues of CAD $2.693 million, +39% QoQ EverGen simultaneously reported that their 4Q21 EBITDA was impacted by the flooding…
-
Golden Matrix Group Inc. (NASDAQ: GMGI) Records 14th Profitable Quarter on the Trot
Golden Matrix Group is a gaming technology and e-sports company, operating its own gaming IP alongside providing white-label gaming platforms for third-parties Golden Matrix reports Revenues of $8,877,105 & net income of $349,379 in the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space
InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Plans to Report Q1 2022 Results on May 16
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced its intention to release its first quarter 2022 financial results after market close on Monday, May 16, 2022. As part of that release…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Bridge Divide Between Cutting-Edge Science and Automotive Industry
Cepton (NASDAQ: CPTN) recently became a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II. The program is designed to…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands
Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Building on Growth Momentum to Bring Cutting-Edge Solutions
SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company appears poised to build upon its growth momentum to expand…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Executing Aggressive Growth Strategy
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of renewable natural…
-
MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and…
-
Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial
Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch
- MissionIRNewsBreaks – New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Unearths Modern Potential in Bolivia’s Silver Story
- BluSky AI Inc. (BSAI) Secures First 9.3 MW Site for Flagship Data Center
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Launches Electric Boating Division at Nautical Ventures